Biopsychosocial model |
|
|
Clinical Trial: Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)
This study is no longer recruiting patients.
|
Purpose
Policy makers and consumers are increasingly concerned about the quality and efficiency of care provided to individuals with severe, chronic illnesses such as schizophrenia. These illnesses are expensive to treat and present significant challenges to organizations that are responsible for providing effective care.
Occurring in 1% of the United States population, schizophrenia accounts for 10% of permanently disabled people, and 2.5% of all healthcare expenditures. Clinical practice guidelines have been promulgated. Schizophrenia is treatable and outcomes can be substantially improved with the appropriate use of antipsychotic medication, caregiver education and counseling, vocational rehabilitation, and assertive treatment. However, in the Department of Veteran''''s Affairs (VA) and other mental health systems, many patients with schizophrenia receive substandard care. Methods are needed that improve the quality of usual care for this disorder while being feasible to implement at typical clinics.
To date, most efforts to improve care for schizophrenia have focused on educating clinicians or changing the financing of care, and have had limited success. The investigators believe a more fundamental approach should be tried. While there are many potential strategies, experience in chronic medical illness and mental health supports the efficacy of specific approaches. Collaborative care models are one such approach. They are a blueprint for reorganizing practice, and involve changes in division of labor and responsibility, adoption of new care protocols, and increased attention to patients’ needs. Although collaborative care models have been successful in other chronic medical conditions, they have not yet been studied in the treatment of schizophrenia.
The investigators have developed a collaborative care model for schizophrenia that builds on work in other disorders, and includes service delivery approaches that are known to be effective in schizophrenia. The model focuses on improving treatment through assertive care management, caregiver education and support, and standardized patient assessment with feedback of information to psychiatrists. This project, "EQUIP" (Enhancing Quality Utilization In Psychosis) is implementing collaborative care and evaluating its effectiveness in schizophrenia. The objective of this project is to implement the care model at two large VA mental health centers, and evaluate its effect on clinicians; the organization of care; and treatment appropriateness, utilization and outcomes in veterans with schizophrenia. The investigators hypothesize that this care model will increase provider adherence to treatment guidelines and improve the quality of care. The investigators will describe implementation of the model, and barriers and facilitators to its implementation. They will evaluate the model by comparing treatment under the care model with usual care. Changes in the structure of care are evaluated using qualitative methods. EQUIP is a controlled trial of the care model. Psychiatrists are randomly assigned to either the new care model or to continue with usual care. Data sources include patient interviews, clinician interviews, and data from VistA. The feasibility of more broadly implementing the collaborative care model is assessed utilizing qualitative and quantitative information about the model''''s strengths and weaknesses, factors that facilitate/impede implementation, direct costs of implementation and maintenance, and effects on treatment service utilization.
| Condition | Intervention |
|---|---|
| Schizophrenia Chronic Illness Schizoaffective Disorder Weight Gain | Procedure: Collaborative Chronic Illness Model |
MedlinePlus related topics: Mental Health; Schizophrenia
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Safety/Efficacy Study
Expected Total Enrollment: 375
Study start: January 2001; Study completion: September 2005
Eligibility
Inclusion Criteria:
Providers (psychiatrists, case managers, nurses):
- Must be working at one of the participating VA mental health clinics
Patients:
- At least 18 years old
- Diagnosis of schizophrenia, schizoaffective, or schizophreniform disorder
- At least 2 treatment visits with a psychiatrist at the clinic during the previous 6 months
Location Information
California
VA Greater Los Angeles Health Care System, Los Angeles, California, 90073, United States
More Information
Last Updated: July 20, 2005
Record first received: July 12, 2005
ClinicalTrials.gov Identifier: NCT00119574
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-02

Not Signed In -


